United States, Japan and Australia added to UK fast-track medicines approvals list
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Source: pharmaceutical-journal.com
Page 18 - Access Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Access Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Access Pathway Today - Breaking & Trending Today
Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study
The research conducted at Cedar Clinical Research in Draper is part of the first ever phase 3 program of psilocybin therapy, and the largest of its kind VANCOUVER, BC, May 30, 2023 /PRNewswire/ -... | May 30, 2023
Source: marketscreener.com
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023
More than half of the patients demonstrated remission of depression at 18 months, after a single dose of 25mg investigational COMP360 psilocybin with psychological supportOpen label phase 2 study,... | May 26, 2023
Source: marketscreener.com
COMPASS Pathways: Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023
More than half of the patients demonstrated remission of depression at 18 months, after a single dose of 25mg investigational COMP360 psilocybin with psychological supportOpen label phase 2 study, conducted
Source: finanznachrichten.de
New recognition routes to fast-track UK medicine access
New recognition routes will facilitate faster access to innovative medicines through seven international partners, according to UK’s MHRA.
Source: europeanpharmaceuticalreview.com